Posttraumatic Stress and Substance Use Disorders

Anka A. Vujanovic, PhD, is a licensed clinical psychologist, an associate professor in the Department of Psychology, and director of the Trauma and Stress Studies Center at the University of Houston. Sudie E. Back, PhD, is a licensed clinical psychologist, a professor in the Department of Psychiatry and Behavioral Sciences, and director of the Drug Abuse Research Training (DART) program at the Medical University of South Carolina.

I. Overview 1. PTSD and Substance Use Disorders: A Clinical Overview 2. Development of Comorbid PTSD and Substance Use Disorders 3. Physical and Mental Health and Other Functional Outcomes in Co-Occurring PTSD and Substance Use Disorders 4. Sex and Gender Differences in PTSD and Substance Use Disorder Comorbidity 5. PTSD and Substance Use Disorders: Consideration of Ethnicity, Race, and Culture II. Assessment and Diagnosis 6. Changes from DSM-IV to DSM-5: PTSD and Substance Use Disorders 7. Assessment of PTSD in the Context of Substance Use Disorders 8. Assessment of Substance Use Disorders in Individuals with PTSD III. Treatment Approaches 9. Risk Reduction through Family Therapy (RRFT): Exposure-Based Treatment for Co-Occurring PTSD and Substance Use Problems among Adolescents 10. Seeking Safety: A Present-Focused Integrated Treatment for PTSD and Substance Use Disorders 11. COPE: Overview of an Exposure-Based Treatment of PTSD and Substance Use Disorders 12. Integrated Cognitive Behavioral Therapy (ICBT) for Co-Occurring PTSD and Substance Use Disorders: Overview and New Applications 13. Pharmacotherapies for PTSD and Substance Use Disorders 14. Third-Wave Behavioral Therapies for the Co-Occurrence of PTSD and Substance Use Disorders IV. Future Directions for Treatment 15. Genetic Studies of PTSD and Substance Use Disorders: Background, Developments, and Future Directions 16. Treating PTSD in a Residential Substance Use Disorder Treatment Program 17. New Directions in PTSD and Substance Use Treatment: Leveraging Technology to Expand Reach 18. Transdiagnostic Treatments: History and Potential for Treating PTSD and Substance Use Disorders